Matches in SemOpenAlex for { <https://semopenalex.org/work/W3167496540> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- W3167496540 endingPage "54" @default.
- W3167496540 startingPage "51" @default.
- W3167496540 abstract "Background: Kidney stones has got high prevalence worldwide especially in our part of world and per-cutaneous nephrolithotomy (PCNL) is gold standard operative modality for renal stone management. Pain control after PCNL is the most important task for treating surgeon as effective pain control causes smooth patient recovery in post-operative period. For analgesia, many drugs can be used, out of which tramadol and nalbuphine always been in comparison for effective analgesic activity. Objective: To compare efficacy of tramadol and nalbuphine as potent analgesic in patients after PCNL. Study Design: A prospective randomized study. Settings: Department of Urology and Kidney Transplantation, Allied Hospital/Faisalabad Medical University, Faisalabad and Department of Urology, DHQ Hospital/Faisalabad Medical University, Faisalabad Pakistan. Duration: From September 2016 to September 2020 (4 Years). Methodology: 286 patients undergoing PCNL for either gender and sides enrolled in study according to inclusion and exclusion criteria. Patients divided into Group A (Administered with tramadol) and Group B (administered with nalbuphine) and patients evaluated for pain up to 48 hours after surgery using 11-point numerical pain rating scale rating from0-10 where 0 is no pain, 1-3 mild pain, 4-6 moderate pain, 7-9 severe pain and 10 as worst pain and use of rescue analgesia observed in either groups. Data obtained and statistical evaluation done. Results: 286 patients enrolled from age 15-75 years with mean age of 40.2 years. Among 286 patients, 161 were male and 125 were female patients. Both groups A and B having 143 patients each. Analysis showed that tramadol has superiority over nalbuphine and need of analgesia is more in patient given nalbuphine (118 vs 31) as maintenance analgesic agent in post-operative period after PCNL. Conclusion: This study showed that tramadol has superiority over nalbuphine for analgesia after PCNL." @default.
- W3167496540 created "2021-06-22" @default.
- W3167496540 creator A5048927751 @default.
- W3167496540 creator A5051732907 @default.
- W3167496540 creator A5068881169 @default.
- W3167496540 creator A5078089731 @default.
- W3167496540 creator A5080023121 @default.
- W3167496540 date "2021-03-31" @default.
- W3167496540 modified "2023-09-25" @default.
- W3167496540 title "Tramadol or Nalbuphine; Which One is Superior for Analgesia in Post-Operative Period after Percutaneous Nephrolithotomy" @default.
- W3167496540 doi "https://doi.org/10.29054/apmc/2021.1062" @default.
- W3167496540 hasPublicationYear "2021" @default.
- W3167496540 type Work @default.
- W3167496540 sameAs 3167496540 @default.
- W3167496540 citedByCount "0" @default.
- W3167496540 crossrefType "journal-article" @default.
- W3167496540 hasAuthorship W3167496540A5048927751 @default.
- W3167496540 hasAuthorship W3167496540A5051732907 @default.
- W3167496540 hasAuthorship W3167496540A5068881169 @default.
- W3167496540 hasAuthorship W3167496540A5078089731 @default.
- W3167496540 hasAuthorship W3167496540A5080023121 @default.
- W3167496540 hasBestOaLocation W31674965401 @default.
- W3167496540 hasConcept C126322002 @default.
- W3167496540 hasConcept C141071460 @default.
- W3167496540 hasConcept C168563851 @default.
- W3167496540 hasConcept C170493617 @default.
- W3167496540 hasConcept C2778977083 @default.
- W3167496540 hasConcept C2779777798 @default.
- W3167496540 hasConcept C2780813298 @default.
- W3167496540 hasConcept C2780820201 @default.
- W3167496540 hasConcept C2780885103 @default.
- W3167496540 hasConcept C2781063702 @default.
- W3167496540 hasConcept C42219234 @default.
- W3167496540 hasConcept C71924100 @default.
- W3167496540 hasConceptScore W3167496540C126322002 @default.
- W3167496540 hasConceptScore W3167496540C141071460 @default.
- W3167496540 hasConceptScore W3167496540C168563851 @default.
- W3167496540 hasConceptScore W3167496540C170493617 @default.
- W3167496540 hasConceptScore W3167496540C2778977083 @default.
- W3167496540 hasConceptScore W3167496540C2779777798 @default.
- W3167496540 hasConceptScore W3167496540C2780813298 @default.
- W3167496540 hasConceptScore W3167496540C2780820201 @default.
- W3167496540 hasConceptScore W3167496540C2780885103 @default.
- W3167496540 hasConceptScore W3167496540C2781063702 @default.
- W3167496540 hasConceptScore W3167496540C42219234 @default.
- W3167496540 hasConceptScore W3167496540C71924100 @default.
- W3167496540 hasIssue "1" @default.
- W3167496540 hasLocation W31674965401 @default.
- W3167496540 hasOpenAccess W3167496540 @default.
- W3167496540 hasPrimaryLocation W31674965401 @default.
- W3167496540 hasRelatedWork W1544453927 @default.
- W3167496540 hasRelatedWork W2279983419 @default.
- W3167496540 hasRelatedWork W2325422954 @default.
- W3167496540 hasRelatedWork W2334386997 @default.
- W3167496540 hasRelatedWork W2542795231 @default.
- W3167496540 hasRelatedWork W2895428558 @default.
- W3167496540 hasRelatedWork W2963774981 @default.
- W3167496540 hasRelatedWork W3013220696 @default.
- W3167496540 hasRelatedWork W4205371642 @default.
- W3167496540 hasRelatedWork W4307328685 @default.
- W3167496540 hasVolume "15" @default.
- W3167496540 isParatext "false" @default.
- W3167496540 isRetracted "false" @default.
- W3167496540 magId "3167496540" @default.
- W3167496540 workType "article" @default.